Subgroups
Protocols (3)
Outcomes & scoring
safety-adverse-reactions-injection-site-hematoma-pain-arthralgia-swelling-occurrence-binary-measured1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-injection-hylan-g-f20-three-weekly-dose-specific-generic | -15 | 50 | 189 |
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-injection-hylan-synvisc-intra-articular-three-weekly-generic | -15 | 50 | 222 |
safety-serious-adverse-events-count-cohort-measured3 evidence rows
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-injection-hylan-g-f20-synvisc-three-weekly-generic | -10 | 40 | 199 |
| therapy-injection-hylan-g-f20-three-weekly-dose-specific-generic | -15 | 50 | 189 |
| therapy-injection-hylan-synvisc-intra-articular-three-weekly-generic | -10 | 50 | 222 |
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-injection-hylan-g-f20-synvisc-three-weekly-generic | -15 | 50 | 199 |
Path: therapy › injection › hylan